Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review
- PMID: 25848702
- DOI: 10.1080/10408398.2013.865590
Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review
Abstract
Despite advances in antiemetic therapy, chemotherapy-induced nausea and vomiting (CINV) still poses a significant burden to patients undergoing chemotherapy. Nausea, in particular, is still highly prevalent in this population. Ginger has been traditionally used as a folk remedy for gastrointestinal complaints and has been suggested as a viable adjuvant treatment for nausea and vomiting in the cancer context. Substantial research has revealed ginger to possess properties that could exert multiple beneficial effects on chemotherapy patients who experience nausea and vomiting. Bioactive compounds within the rhizome of ginger, particularly the gingerol and shogaol class of compounds, interact with several pathways that are directly implicated in CINV in addition to pathways that could play secondary roles by exacerbating symptoms. These properties include 5-HT3, substance P, and acetylcholine receptor antagonism; antiinflammatory properties; and modulation of cellular redox signaling, vasopressin release, gastrointestinal motility, and gastric emptying rate. This review outlines these proposed mechanisms by discussing the results of clinical, in vitro, and animal studies both within the chemotherapy context and in other relevant fields. The evidence presented in this review indicates that ginger possesses multiple properties that could be beneficial in reducing CINV.
Keywords: CINV; Ginger; chemotherapy; nausea; vomiting.
Similar articles
-
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin.Ann Oncol. 2017 Oct 1;28(10):2547-2551. doi: 10.1093/annonc/mdx315. Ann Oncol. 2017. PMID: 28666335 Clinical Trial.
-
Zingiber officinale (ginger) as an anti-emetic in cancer chemotherapy: a review.J Altern Complement Med. 2012 May;18(5):440-4. doi: 10.1089/acm.2010.0737. Epub 2012 Apr 27. J Altern Complement Med. 2012. PMID: 22540971 Review.
-
Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting.Support Care Cancer. 2009 May;17(5):563-72. doi: 10.1007/s00520-008-0528-8. Epub 2008 Nov 13. Support Care Cancer. 2009. PMID: 19005687 Free PMC article. Clinical Trial.
-
Does the Oral Administration of Ginger Reduce Chemotherapy-Induced Nausea and Vomiting?: A Meta-analysis of 10 Randomized Controlled Trials.Cancer Nurs. 2019 Nov/Dec;42(6):E14-E23. doi: 10.1097/NCC.0000000000000648. Cancer Nurs. 2019. PMID: 30299420
-
Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature review.Nutr Rev. 2013 Apr;71(4):245-54. doi: 10.1111/nure.12016. Epub 2013 Mar 13. Nutr Rev. 2013. PMID: 23550785 Review.
Cited by
-
Phytonutrients in the promotion of healthspan: a new perspective.Front Nutr. 2024 Jul 12;11:1409339. doi: 10.3389/fnut.2024.1409339. eCollection 2024. Front Nutr. 2024. PMID: 39070259 Free PMC article. Review.
-
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.ESMO Open. 2024 Feb;9(2):102195. doi: 10.1016/j.esmoop.2023.102195. Epub 2024 Jan 11. ESMO Open. 2024. PMID: 38458657 Free PMC article.
-
Effect of ginger supplementation on the fecal microbiome in subjects with prior colorectal adenoma.Sci Rep. 2024 Feb 5;14(1):2988. doi: 10.1038/s41598-024-52658-4. Sci Rep. 2024. PMID: 38316805 Free PMC article. Clinical Trial.
-
Interpreting the efficacy enhancement mechanism of Chinese medicine processing from a biopharmaceutic perspective.Chin Med. 2024 Jan 18;19(1):14. doi: 10.1186/s13020-024-00887-0. Chin Med. 2024. PMID: 38238801 Free PMC article. Review.
-
Effect of Zingiber Officinale in the Management of Nausea and Vomiting Induced by Treatment With Cisplatin Associated With Radiotherapy: A Randomized Controlled Trial.Integr Cancer Ther. 2023 Jan-Dec;22:15347354231220608. doi: 10.1177/15347354231220608. Integr Cancer Ther. 2023. PMID: 38140826 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical